A systematic review comparing allogeneic hematopoietic stem cell transplant to gene therapy in sickle cell disease-Reference-Cited by-同舟云学术

A systematic review comparing allogeneic hematopoietic stem cell transplant to gene therapy in sickle cell disease

Published:2023-02-02 Issue:1 Volume:28 Page:
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Rotin Lianne E.¹²,Viswabandya Auro²³,Kumar Rajat²³,Patriquin Christopher J.²⁴,Kuo Kevin H.M.²⁴⁵^ORCID

Affiliation:

1. Division of General Internal Medicine, Department of Medicine, University of Toronto, Toronto, Canada

2. Division of Hematology, Department of Medicine, University of Toronto, Toronto, Canada

3. Messner Allogeneic Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

4. Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Toronto, Canada

5. Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada

Funder

MACK Foundation

National Heart, Lung, and Blood Institute of the National Institutes of Health

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2022.2163357

Reference124 articles.

1. Factors associated with survival in a contemporary adult sickle cell disease cohort

2. Survival in adults with sickle cell disease in a high-income setting

3. Curative approaches for sickle cell disease: A review of allogeneic and autologous strategies

4. Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease

5. Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates in Pediatric Sickle Cell Lung Disease;Clinics in Chest Medicine;2024-09

2. Good engraftment after reduced intensity targeted busulfan‐based conditioning and matched related donor hematopoietic cell transplantation in hemoglobinopathies;Pediatric Blood & Cancer;2024-04-12

3. Systemic medications for sickle cell disease and potential applications for sickle cell retinopathy;Current Opinion in Ophthalmology;2024-03-08

4. Life after sickle cell disease, is it really uhuru?;The Lancet Haematology;2023-12

5. Outcomes and long-term effects of hematopoietic stem cell transplant in sickle cell disease;Expert Review of Hematology;2023-10-12